Can a website replace your doctor for Alzheimer's risk news?
NCT ID NCT06459583
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether an online platform can effectively share Alzheimer's gene and biomarker test results with 681 participants, compared to a video call with a healthcare provider. The goal was to see if the self-guided method causes similar levels of anxiety, distress, and understanding. This research helps improve how risk information is delivered without overwhelming patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accellacare Clinical Research Site 01
Bristol, Tennessee, 37620, United States
-
Accellacare Clinical Research Site 02
Mt. Pleasant, South Carolina, 29464, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking thousands of dementia cases reshape how we care for patients?
- PET scans probe link between brain inflammation and Alzheimer's damage
- Can sound waves soothe Dementia's emotional turmoil?
- Can a Low-Dose immune calmer slow Alzheimer's decline?
- A stumble before memory slips? study tests if falls predict Alzheimer's
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?